Annette Regan

(she/her/hers)
Only one antiviral medication is approved by the FDA for RSV treatment, and it is administered through a nebulizer. BonNontawat/iStock via Getty Images Plus

RSV treatments for young children are lacking, but the record 2022 cold and flu season highlights the urgency for vaccines and other preventive strategies

While RSV can become severe for any child, it poses a particularly serious threat for the youngest babies and for high-risk children.
Pediatric emergency rooms in some states are at or over capacity due to the surging number of respiratory infections. GOLFX/iStock via Getty Images Plus

COVID‑19, RSV and the flu are straining health care systems – two epidemiologists explain what the ‘triple threat’ means for children

Respiratory viruses are hitting young children and infants particularly hard this fall and winter season, and experts don’t yet know exactly why.

Contact Annette for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision